These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19597135)

  • 1. Seropositive myasthenia gravis: a nationwide epidemiologic study.
    Heldal AT; Owe JF; Gilhus NE; Romi F
    Neurology; 2009 Jul; 73(2):150-1. PubMed ID: 19597135
    [No Abstract]   [Full Text] [Related]  

  • 2. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
    Somnier FE
    Neurology; 2005 Sep; 65(6):928-30. PubMed ID: 16186537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult onset acquired myasthenia gravis in three Great Dane littermates.
    Kent M; Glass EN; Acierno M; Shelton GD
    J Small Anim Pract; 2008 Dec; 49(12):647-50. PubMed ID: 18684140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile myasthenia gravis in Norway: A nationwide epidemiological study.
    Popperud TH; Boldingh MI; Brunborg C; Faiz KW; Heldal AT; Maniaol AH; Müller KI; Rasmussen M; Øymar K; Kerty E
    Eur J Paediatr Neurol; 2017 Mar; 21(2):312-317. PubMed ID: 27666466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of seropositive myasthenia gravis in Cape Town and South Africa.
    Bateman KJ; Schinkel M; Little F; Liebenberg L; Vincent A; Heckmann JM
    S Afr Med J; 2007 Oct; 97(10):959-62. PubMed ID: 18000579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease.
    Toth C; McDonald D; Oger J; Brownell K
    Acta Neurol Scand; 2006 Aug; 114(2):124-32. PubMed ID: 16867036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime course of myasthenia gravis.
    Grob D; Brunner N; Namba T; Pagala M
    Muscle Nerve; 2008 Feb; 37(2):141-9. PubMed ID: 18059039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical statistics of myasthenia gravis in Japan.
    Uono MI
    Int J Neurol; 1980; 14(1):87-99. PubMed ID: 6983511
    [No Abstract]   [Full Text] [Related]  

  • 9. Geographical distribution of a seropositive myasthenia gravis population.
    Heldal AT; Eide GE; Gilhus NE; Romi F
    Muscle Nerve; 2012 Jun; 45(6):815-9. PubMed ID: 22581533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing incidence of myasthenia gravis among elderly in British Columbia, Canada.
    Pakzad Z; Aziz T; Oger J
    Neurology; 2011 Apr; 76(17):1526-8. PubMed ID: 21519005
    [No Abstract]   [Full Text] [Related]  

  • 11. Inherited predisposition to myasthenia gravis in Newfoundlands.
    Lipsitz D; Berry JL; Shelton GD
    J Am Vet Med Assoc; 1999 Oct; 215(7):956-8, 946. PubMed ID: 10511859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia gravis is a rare but treatable disease.
    Mombaur B; Heckmann JM
    S Afr Med J; 2015 Aug; 105(8):619. PubMed ID: 26543935
    [No Abstract]   [Full Text] [Related]  

  • 13. 'Seronegative' myasthenia gravis is no longer seronegative.
    Lindstrom J
    Brain; 2008 Jul; 131(Pt 7):1684-5. PubMed ID: 18558616
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. 1975.
    Lindstrom JM; Seybold ME; Lennon VA; Whittingham S; Duane DD
    Neurology; 1998 Oct; 51(4):933 and 6 pages following. PubMed ID: 9781505
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-MuSK myasthenia gravis presenting with Epstein-Barr virus-associated mononucleosis and immune-mediated diabetes mellitus.
    Bhibhatbhan A; Kline G; Vincent A; Toth C
    Muscle Nerve; 2007 Aug; 36(2):264-6. PubMed ID: 17266132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica.
    McKeon A; Lennon VA; Jacob A; Matiello M; Lucchinetti CF; Kale N; Chan KH; Weinshenker BG; Apiwattinakul M; Wingerchuk DM; Pittock SJ
    Muscle Nerve; 2009 Jan; 39(1):87-90. PubMed ID: 19086079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis: a higher than expected incidence in the elderly.
    Aragonès JM; Bolíbar I; Bonfill X; Bufill E; Mummany A; Alonso F; Illa I
    Neurology; 2003 Mar; 60(6):1024-6. PubMed ID: 12654975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of seropositive myasthenia gravis in Greece.
    Poulas K; Tsibri E; Kokla A; Papanastasiou D; Tsouloufis T; Marinou M; Tsantili P; Papapetropoulos T; Tzartos SJ
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):352-6. PubMed ID: 11511710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anesthetic considerations for thymectomy in a patient having an anti-acetylcholine receptor antibody without myasthenia gravis].
    Koshida T; Hara K; Obara G; Sata T
    Masui; 2008 Aug; 57(8):993-5. PubMed ID: 18710007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
    Saulat B; Maertens P; Hamilton WJ; Bassam BA
    Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.